Register Login

Chromogenic Factor VIII Assay FDA-Cleared

On Monday, July 20, Fritsma Factor sponsor Precision BioLogic Inc. announced  US FDA 510[k] clearance of their CRYOcheck™ Chromogenic Factor VIII assay. The assay had been previously approved in Canada, the European Union, Australia, and New Zealand. The assay boasts a test range from 0–200% FVIII using one standard curve and a limit of quantitation below 1%. Click here for Precision’s press release.

In August, Precision BioLogic will be hosting a free online webinar to review the benefits of chromogenic factor VIII testing and highlight the new CRYOcheck™ Chromogenic Factor VIII assay. To be notified of webinar details, sign up at We look forward to connecting with you at the webinar.

Comments (0)
Bleeding Disorders

No comments here.

Leave a Reply